{
 "name": "禾生技",
 "slug": "tw-4194",
 "aliases": [
  "禾伸堂生技股份有限公司",
  "HSHC",
  "4194"
 ],
 "ticker": "4194",
 "industry": "生技醫療業",
 "website": "www.hshc.com.tw",
 "summary": "禾生技（4194）是興櫃的生技醫療類股公司，2001 年成立，2013 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "禾伸堂生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "HSHC",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2013-12-13",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2001-01-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "唐錦榮",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "楊晴華",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 1459744000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "www.hshc.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：CA102N（nimesulide－透明質酸共軛物）",
   "value": "轉移性大腸直腸癌合併TAS-102｜第二期試驗暫停｜美國",
   "unit": "",
   "as_of": "2026-09-18",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06039202",
   "note": "NCT06039202；as_of=Last Update Posted。SUSPENDED；whyStopped=Strategy under discussion。地區取本筆登錄locations；不沿用2023年公司規劃之台灣／韓國地區。登錄預估開始2027-12但仍暫停，未當確定啟動催化劑。"
  },
  {
   "claim": "管線：IBD98-M（mesalamine／sodium hyaluronic）",
   "value": "潰瘍性結腸炎｜第二期試驗已完成（歷史登錄）｜義大利",
   "unit": "",
   "as_of": "2021-10-26",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT02493712",
   "note": "NCT02493712；as_of=Last Update Posted。"
  },
  {
   "claim": "管線：IBD98-M（mesalamine／透明質酸緩釋膠囊）",
   "value": "輕中度潰瘍性結腸炎｜已獲准第二期人體試驗（2023年公告）｜中國",
   "unit": "",
   "as_of": "2023-05-19",
   "source": "https://www.hshc.com.tw/zh-tw/bulletin_info.php?id=72",
   "note": "公司公告接獲NMPA IND通知；不是上市許可。原估2026-06收案完成已過，本輪未取得新完成證據，故不列未來催化劑。"
  },
  {
   "claim": "管線：ND108E（透明質酸－雌激素共軛物）",
   "value": "停經後阿茲海默症相關認知障礙｜臨床前研究｜開發地區未揭露",
   "unit": "",
   "as_of": "2023-10-24",
   "source": "https://www.hshc.com.tw/zh-tw/bulletin_info.php?id=73",
   "note": "公司於CTAD展示臨床前資料；波士頓是會議地點，不當臨床試驗地區。官網現行pipeline另列IND-enabling，該頁未標發布日，不覆寫日期。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4194.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}